IDRI Announces New VP Tuberculosis Drug Development: Gail H. Cassell, PhD, to Join IDRI

December 7th, 2011|Press Releases|

Seattle, WA | December 7, 2011 The Infectious Disease Research Institute (IDRI) announced today that Dr. Gail H. Cassell has joined IDRI as its Vice President, TB Drug Development. In this newly created position, Dr. Cassell will work within [...]

IDRI to Present at India — US Forum: Dr. Christopher Fox to Discuss IDRI’s Technology Transfer Efforts

November 29th, 2011|Press Releases|

Seattle, WA | November 29, 2011 The Infectious Disease Research Institute (IDRI) announced today that IDRI formulation scientist Dr. Christopher Fox will present at this week's Forum on The US-India Commercial Relationship: The Knowledge Economy. The forum, to be [...]

Eli Lilly and Company Provides IDRI with Additional Funding for Identification of New Tuberculosis Therapies

November 17th, 2011|Press Releases|

Seattle, WA | November 17, 2011 The Infectious Disease Research Institute (IDRI) has been awarded more than $4 million in additional funding over the next four and a half years by Eli Lilly and Company. The funding will support [...]

IDRI Partners with Global Research Initiative ADITEC to Accelerate Human Vaccine Development

October 17th, 2011|Press Releases|

Seattle, WA | October 17, 2011 The Infectious Disease Research Institute (IDRI) has joined the Advanced Immunization Technologies (ADITEC) program, a collaborative initiative dedicated to accelerating the development of the next generation of human vaccines. Launched on October 1st, [...]

The Paul G. Allen Family Foundation Supports Launch of IDRI’s TB Vaccine Clinical Program

October 12th, 2011|Press Releases|

Seattle, WA | October 12, 2011 The Infectious Disease Research Institute (IDRI) has been awarded a two-year $300,000 grant from The Paul G. Allen Family Foundation to support IDRI's launch of a Phase 1 clinical trial of its new [...]

GlaxoSmithKline Donates Scientific Equipment to Advance IDRI’s Global Health Mission

October 3rd, 2011|Press Releases|

Seattle, WA | October 3, 2011 The Infectious Disease Research Institute (IDRI) announces today that GlaxoSmithKline (GSK) Biologicals Hamilton has donated a broad range of instrumentation and equipment that will assist IDRI as it designs and validates solutions to [...]

IDRI Launches New and Improved Website

September 7th, 2011|Press Releases|

Seattle, WA | September 7, 2011 The Infectious Disease Research Institute (IDRI) announced today the launch of its new and improved website,www.idri.org. IDRI's website now boasts a revitalized design, streamlined navigation, and expanded information about its product pipeline, with [...]

IDRI, USAID Strike New Collaboration for Malaria Vaccine Development

August 16th, 2011|Press Releases|

Seattle, WA | August 16, 2011 The Infectious Disease Research Institute (IDRI) today announced a new Memorandum of Understanding with the United States Agency for International Development (USAID), focused on support of a collaboration with the Walter Reed Army [...]

IDRI Announces New EVP Business Development & External Affairs

August 2nd, 2011|Press Releases|

Seattle, WA | August 2, 2011 The Infectious Disease Research Institute (IDRI) announced today that Erik Iverson, Associate General Counsel for Global Health at the Bill & Melinda Gates Foundation, will join IDRI in September as its EVP Business [...]

IDRI Announces Appointment of H. Stewart Parker as Chief Executive Officer

February 15th, 2011|Press Releases|

Seattle, WA | February 15, 2011 The Infectious Disease Research Institute (IDRI) announces today the appointment of H. Stewart Parker as its new Chief Executive Officer and new member of the IDRI board of directors. Parker is a widely [...]

Load More